Acan | aggrecan
Physiological systems
17 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Immune system Hematopoietic system Mortality/aging
14 No significant impact
7 Not tested
Gene metrics:2Significant phenotypes
7Associated diseases
Expression examined in:46Adult tissues
42Embryo tissues
preweaning lethality, complete penetrance | 1 supporting dataset | Acantm1b(EUCOMM)Hmgu | homozygote | Early adult | N/A * | ||
increased basophil cell number | 1 supporting dataset | Acantm1b(EUCOMM)Hmgu | heterozygote | Early adult | 2.4x10-5 |
| | | | | | | | | |
External links
No external links available for Acan.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Acantm1(EGFP_CreERT2)Wtsi | Reporter-tagged deletion allele (with selection cassette) | | ES Cell |
Acantm1.1(EGFP/cre/ERT2)Wtsi | Reporter-tagged deletion allele (post Cre, with no selection cassette) | | ES Cell mouse |
Acantm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Acantm1b(EUCOMM)Hmgu | Reporter-tagged deletion allele (with selection cassette) | | mouse |
Acantm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |